You are viewing the site in preview mode
Skip to main content
| |
MVS group (n = 20)
|
PMVR group (n = 23)
|
OPCAB group (n = 25)
|
p-value
|
|---|
|
Male, n
|
13 (65%)
|
13 (57%)
|
19 (76%)
|
0.21
|
|
Age, years
|
60 ± 20
|
74 ± 12
|
71 ± 9
|
0.03*
|
|
NYHA class
|
II (I, III)
|
III (III, VI)
|
II (I, III)
|
< 0.001***
|
|
EuroSCORE II, %
|
4.0 ± 7.2
|
13.5 ± 12.4
|
6.0 ± 9.4
|
< 0.01**
|
|
Type of surgery
|
|
Replacement
|
7 (35%)
|
–
|
–
| |
|
Repair
|
13 (65%)
|
–
|
–
| |
|
General anesthesia
|
20 (100%)
|
5 (22%)
|
25 (100%)
|
< 0.001***
|
|
Nr. of clips applied, n
|
|
1
|
–
|
12 (52%)
|
–
| |
|
2
|
–
|
10 (44%)
|
–
| |
|
3
|
–
|
1 (4%)
|
–
| |
|
reduced LVEF, n
|
2 (10%)
|
21 (91%)
|
13 (52%)
|
< 0.001***
|
|
elevated PAPsys, n
|
5 (25%)
|
16 (70%)
|
2 (8%)
|
< 0.001***
|
|
CAD, n
|
0 (0%)
|
19 (89%)
|
25 (100%)
|
< 0.001***
|
|
RCA revascularization, n
|
–
|
–
|
16 (64%)
| |
|
RVEDV, ml
|
137 ± 37
|
168 ± 76
|
145 ± 49
|
0.24
|
|
RVESV, ml
|
91 ± 38
|
113 ± 58
|
89 ± 43
|
0.25
|
|
GFR < 50 ml/min, n
|
2 (10%)
|
7 (30%)
|
5 (20%)
|
0.25
|
|
CPB / procedure time, min
|
134 ± 32
|
106 ± 49
|
227 ± 53
|
< 0.001***
|
- CPB cardiopulmonary bypass, CHD coronary artery disease, GFR glomerular filtration rate, LVEF left ventricular ejection fraction (considered reduced if < 50% preoperatively), NYHA New York Heart Association, PAPsys systolic pulmonary artery pressure (considered increased if > 30 mmHg preoperatively), RCA right coronary artery, RVEDV right ventricular end-diastolic volume (measured intraoperatively before sternotomy / before mitral valve clipping), RVESV right ventricular end-systolic volume (measured intraoperatively before sternotomy / before mitral valve clipping)
